An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol

Manoop S. Bhutani, Jason B. Klapman, Richard Tuli, Ghassan El-Haddad, Sarah Hoffe, Franklin C.L. Wong, Beth Chasen, David R. Fogelman, Simon K. Lo, Nicholas N. Nissen, Andrew E. Hendifar, Gauri Varadhachary, Matthew H.G. Katz, William D. Erwin, Eugene J. Koay, Eric P. Tamm, Ben S. Singh, Rutika Mehta, Robert A. Wolff, Ashish SomanIrina M. Cazacu, Joseph M. Herman

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Current treatment options for patients with unresectable locally advanced pancreatic cancer (LAPC) include chemotherapy alone or followed by chemoradiation or stereotactic body radiotherapy. However, the prognosis for these patients remains poor, with a median overall survival <12 months. Therefore, novel treatment options are needed. Currently, there is no brachytherapy device approved for pancreatic cancer treatment. Hereby, we present the protocol of a prospective, multicenter, interventional, open-label, single-arm pilot study (OncoPac-1, Clinicaltrial.gov-NCT03076216) aiming to determine the safety and efficacy of Phosphorus-32 when implanted directly into pancreatic tumors using EUS guidance, for patients with unresectable LAPC undergoing chemotherapy (gemcitabine ± nab-paclitaxel).

Original languageEnglish (US)
Pages (from-to)24-30
Number of pages7
JournalEndoscopic Ultrasound
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2020

Keywords

  • Brachytherapy
  • Chemotherapy
  • EUS
  • Endoscopy
  • Fine needle injection
  • Intratumoral therapy
  • Neoplasia
  • Pancreatic cancer
  • Phosphorus-32
  • Radiotherapy

ASJC Scopus subject areas

  • Hepatology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Fingerprint Dive into the research topics of 'An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol'. Together they form a unique fingerprint.

Cite this